| Financial Year |
March 31 2023 |
| Monetary Funds |
199,627,438.44 |
| Held-for-trading Financial Assets |
110,046,520.55 |
| Notes Receivable |
-- |
| Accounts Receivable |
148,223,997.74 |
| Advances to Suppliers |
2,132,011.20 |
| Other Receivables |
3,059,730.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,228,953.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,000,000.00 |
| Other Current Assets |
6,264,446.98 |
| Total Current Assets |
561,422,918.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
235,349,566.48 |
| Under-construction Projects |
25,560,913.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,020,129.28 |
| R&D expenses |
-- |
| Goodwill |
3,980,833.90 |
| Long-Term Deferred and Prepaid Expenses |
1,894,850.13 |
| Deferred Income Tax Assets |
4,460,288.28 |
| Other Non-Current Assets |
2,034,965.66 |
| Sub-Total of Non-Current Assets |
455,883,082.13 |
| Total Assets |
1,017,306,000.63 |
| Short-Term Loans |
25,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
111,971,214.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,891,677.25 |
| Taxes Payable |
167,002.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,305,159.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,916,649.66 |
| Other Current Liabilities |
163,995.62 |
| Sub-Total of Current Liabilities |
152,592,722.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,317,392.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,968,159.61 |
| Total Liabilities |
157,560,882.37 |
| Paid-In Capital(Or Share Stock) |
103,154,344.00 |
| Capital Surplus |
374,079,635.54 |
| Surplus Reserve |
36,938,865.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
345,572,639.16 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
859,745,118.26 |
| Owner's Equity（Stockholder's Equity） |
859,745,118.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,017,306,000.63 |
